Medicare, new prices
Digest more
The two-month reprieve extends through January 2026. While some providers are restarting telehealth services, it remains unclear whether eligible virtual care reimbursements, accrued during the 43-day shutdown,
Stocktwits on MSN
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared
Analysts said Medicare’s drug-price cuts were smaller or already reflected in forecasts. ・Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries. ・Retail traders on Stocktwits turned extremely bullish on LABU as message volume surged.